FENNEC PHARMACEUTICALS INC. — Director's Dealing 2017

Sep 20, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2017-09-11

Reporting Person: RALLIS CHRIS A (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.50	2019-11-18	Common Shares (3333)		Direct
Stock Option (right to buy)	$0.60	2020-04-04	Common Shares (8333)		Direct
Stock Option (right to buy)	$0.54	2020-05-17	Common Shares (9259)		Direct
Stock Option (right to buy)	$0.45	2019-08-17	Common Shares (11111)		Direct
Stock Option (right to buy)	$1.05	2020-11-20	Common Shares (4792)		Direct
Stock Option (right to buy)	$2.40	2020-04-03	Common Shares (4166)		Direct
Stock Option (right to buy)	$2.94	2020-05-17	Common Shares (1700)		Direct
Stock Option (right to buy)	$0.96	2020-08-06	Common Shares (5208)		Direct
Stock Option (right to buy)	$0.72	2020-08-23	Common Shares (16666)		Direct
Stock Option (right to buy)	$1.59	2021-01-24	Common Shares (3144)		Direct
Stock Option (right to buy)	$2.31	2021-04-25	Common Shares (4329)		Direct
Stock Option (right to buy)	$3.60	2021-05-15	Common Shares (1389)		Direct
Stock Option (right to buy)	$2.79	2021-08-04	Common Shares (1792)		Direct
Stock Option (right to buy)	$2.55	2021-11-07	Common Shares (1960)		Direct
Stock Option (right to buy)	$2.69	2021-12-31	Common Shares (10000)		Direct
Stock Option (right to buy)	$2.51	2022-03-16	Common Shares (1992)		Direct
Stock Option (right to buy)	$2.30	2022-05-11	Common Shares (2173)		Direct
Stock Option (right to buy)	$2.35	2022-08-03	Common Shares (2127)		Direct
Stock Option (right to buy)	$1.23	2022-11-10	Common Shares (4062)		Direct
Stock Option (right to buy)	$2.44	2023-06-09	Common Shares (4098)		Direct
Stock Option (right to buy)	$2.44	2023-06-09	Common Shares (10246)		Direct
Stock Option (right to buy)	$5.10	2024-06-27	Common Shares (20000)		Direct